Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mevacor Behind-The-Counter Status Is “Not Necessary,” J&J/Merck Says

This article was originally published in The Tan Sheet

Executive Summary

Behind-the-counter access is "not necessary" if Johnson & Johnson/Merck's lipid-lowering drug Mevacor (lovastatin) were switched from prescription status to OTC, the joint venture maintains

You may also be interested in...



Advisory OTCs? GSK Weighs Third Class Paradigm With Xenical In Mind

GlaxoSmithKline Consumer Healthcare is internally discussing the impact a third class of pharmacy-only drugs could have on the self-care market

Advisory OTCs? GSK Weighs Third Class Paradigm With Xenical In Mind

GlaxoSmithKline Consumer Healthcare is internally discussing the impact a third class of pharmacy-only drugs could have on the self-care market

Advisory OTCs? GSK Weighs Third Class Paradigm With Xenical In Mind

GlaxoSmithKline Consumer Healthcare is internally discussing the impact a third class of pharmacy-only drugs could have on the self-care market

Related Content

Topics

UsernamePublicRestriction

Register

LL005491

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel